(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BIOCRYST

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

BIOCRYST

ST13

US500000088073891

Class

5

Filing

88073891

Registration

5713814

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

01/13/2026

Trademark type

Word

Nice classes

5

Filing date

08/10/2018

Registration date

04/02/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/05/2025

Last transaction

01/13/2026

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

First use anywhere

08/14/2007

First use in commerce

08/14/2007

Drawing code

4

Owner type

03

Owner location

Durham, NC

Examiner

SCHWARZ,KATHLEEN MICHELLE HUD

Current location

Historical data usage

Holders and representatives

Holders

BioCryst Pharmaceuticals, Inc.

Representatives

Erica L. Han Ropes & Gray LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceuticals for the treatment of infectiousviralinflammatoryimmunologicalautoimmune and cardiovascular diseases and disorders; pharmaceuticals for the treatment of hereditary angioedemainflammatory bowel diseasesinflammatory connective tissue diseases and inflammatory skin diseases; pharmaceuticals for the treatment of influenzaAIDSSARSEbolaZikaWest Nile virus; pharmaceuticals for the treatment of transplant rejection; anti-infective pharmaceuticals; pharmaceuticals for the treatment of cancercancers of the immune system such as T-cell and B-cell leukemias and lymphomas

Publications

History of USPTO decisions and trademark events.

27 publications found

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

12/03/2025

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

12/02/2025

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

08/05/2025

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

08/05/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/05/2025

E815

TEAS SECTION 8 & 15 RECEIVED

04/01/2025

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

04/02/2024

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

05/03/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/21/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/21/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/21/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/06/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/06/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/06/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/16/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/16/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/16/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/16/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/16/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

04/02/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/15/2019

PUBO

PUBLISHED FOR OPPOSITION

01/15/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/26/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/03/2018

DOCK

ASSIGNED TO EXAMINER

11/28/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/18/2018

NWAP

NEW APPLICATION ENTERED

08/14/2018

Continuous trademark protection

Get notified about every new filing that threatens BIOCRYST or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.